Last edition
News about "Viatris "
Nxera Pharma Assigns Japan Rights to Cenerimod for Autoimmune Diseases to Viatris
Nxera will receive an upfront payment of USD 10 million from Viatris and is eligible to receive a milestone payment upon regulatory approval of cenerimod in Japan plus royalties on net sales should it be commercialized in the assigned territories.
Viatris | 28/02/2025 | By Aishwarya | 125
Viatris Signs Licensing Deal with Lexicon Pharmaceuticals for Sotagliflozin
This licensing agreement leverages Viatris' expertise in cardiovascular diseases and its Global Healthcare Gateway, which offers partners ready access to more markets and patients worldwide through the company's unique global infrastructure and expertise.
Viatris | 18/10/2024 | By Aishwarya | 288
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy